Close
New test could detect breast and ovarian cancer from cervical screening samples
7 February 2022
A new revolutionary test for detecting ovarian and breast cancer, which could potentially measure feature cancer risk is being developed by researchers from UCL's EGA Institute for Women's Health
The research, part of a series of papers published in Nature Communications, is led by Professor Martin Widschwendter (UCL Institute for Women’s Health, University of Innsbruck and the European Translational Oncology Prevention and Screening Institute) and is funded by The Eve Appeal and the European Research Council. For more details - UCL news